Aaron Lerner

Prof. Aaron Lerner


Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2011 in Clinical Reviews in Allergy & Immunology
Verified
Journal Article
Closed access
PDF file
ALAaron Lerner
Aaron Lerner
YSYinon Shapira
Yinon Shapira
NANancy Agmon-Levin
Nancy Agmon-Levin
APAvi Pacht
Avi Pacht
Dana Ben-Ami ShorDana Ben-Ami Shor
Dana Ben-Ami Shor
YSYehuda Shoenfeld
Yehuda Shoenfeld

1 January 2010 in Autoimmunity Reviews
Verified
Journal Article
Closed access
ALAaron Lerner
Aaron Lerner

1 June 2007 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
PDF file
ALAaron Lerner
Aaron Lerner

1 November 2014 in Autoimmunity Reviews
Verified
Journal Article
Closed access
ALAaron Lerner
Aaron Lerner
MBMiri Blank
Miri Blank

4 April 2013 in BMC Medicine
Verified
Journal Article
Open access
PDF file
ALAaron Lerner
Aaron Lerner
NANancy Agmon-Levin
Nancy Agmon-Levin
YSYinon Shapira
Yinon Shapira
BGBoris Gilburd
Boris Gilburd
SRSandra Reuter
Sandra Reuter
Yehuda ShoenfeldYehuda Shoenfeld
Yehuda Shoenfeld
Celiac disease is a life-long autoimmune condition, affecting genetically susceptible individuals that may present with thromboembolic phenomena. This thrombophilia represents a puzzle with multiple constituents: hyperhomocysteinemia, B12 and\or folate deficiency, methylenetetrahydrofolate reductase mutations, and protein C and S deficiency due to vitamin K deficiency. However, the well known thrombogenic factors, antiphosphatidylserine/prothrombin and antiprothrombin have never been explored in celiac disease.

1 December 2010
Verified
Journal Article
Closed access
YOYael Oren
Yael Oren
YSYinon Shapira
Yinon Shapira
Nancy Agmon LevinNancy Agmon Levin
Nancy Agmon Levin
SKShaye Kivity
Shaye Kivity
YZYaron Zafrir
Yaron Zafrir
YSYehuda Shoenfeld
Yehuda Shoenfeld